{"transactions":[{"id":781933,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47899,"kind":"person","name":"Ho William Tai-Wei","position":1,"cik":"0001830914","reported_name":"Ho William Tai-Wei","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-05-12T20:30:27.000Z","date":"2026-05-09","kind":"grant","planned":false,"acquired":true,"shares":154500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to the option shall vest on each of November 9, 2026, May 9, 2027, November 9, 2027 and May 9, 2028, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":154500,"derivative":{"exercise_price":1.58,"expiration_date":"2036-05-09","underlying":"Common Stock","underlying_shares":154500},"source":{"system":"sec-edgar","filing":"0001830914-26-000004","document":"form4-05122026_040514.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1740279/000183091426000004/form4-05122026_040514.xml","form_type":"4"}},{"id":915677,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47899,"kind":"person","name":"Ho William Tai-Wei","position":1,"cik":"0001830914","reported_name":"Ho William Tai-Wei","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-02-06T21:30:22.000Z","date":"2026-02-04","kind":"grant","planned":false,"acquired":true,"shares":206000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to the option shall vest on February 4, 2027 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":206000,"derivative":{"exercise_price":1.96,"expiration_date":"2036-02-04","underlying":"Common Stock","underlying_shares":206000},"source":{"system":"sec-edgar","filing":"0001830914-26-000002","document":"form4-02062026_040216.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1740279/000183091426000002/form4-02062026_040216.xml","form_type":"4"}},{"id":959303,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47899,"kind":"person","name":"Ho William Tai-Wei","position":1,"cik":"0001830914","reported_name":"Ho William Tai-Wei","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2025-12-23T23:20:11.000Z","date":"2025-12-22","kind":"grant","planned":false,"acquired":true,"shares":36232,"price":1.38,"value":50000.16,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Effective June 3, 2025, the Issuer effected a 1-for-30 reverse stock split of the Issuer's common stock. The number of securities reported herein have been adjusted to reflect the reverse stock split."}],"balance_after":121168,"source":{"system":"sec-edgar","filing":"0001830914-25-000003","document":"form4-12232025_061207.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1740279/000183091425000003/form4-12232025_061207.xml","form_type":"4"}},{"id":1155869,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47899,"kind":"person","name":"Ho William Tai-Wei","position":1,"cik":"0001830914","reported_name":"Ho William Tai-Wei","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Pre-Funded Warrant (right to buy)","published_at":"2025-05-08T00:45:13.000Z","date":"2025-05-01","kind":"grant","planned":false,"acquired":true,"shares":81967,"price":0.1843,"value":15106.5181,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Pursuant to an Exchange Letter Agreement, dated April 26, 2025 (the \"Exchange Agreement\"), by and between the Company and the Reporting Person, the Reporting Person surrendered to the Company for cancellation the Series A Warrants for a like number of Pre-Funded Warrants to purchase common stock,  with a per share exercise price of $0.0001 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested and exercisable."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The Pre-Funded Warrants have no expiration date and are exercisable at any time after the date of issuance. The Pre-Funded Warrants are subject to certain exercise limitations."}],"balance_after":81967,"derivative":{"exercise_price":0.0001,"underlying":"Common Stock","underlying_shares":81967},"source":{"system":"sec-edgar","filing":"0001415889-25-012290","document":"form4-05072025_080509.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1740279/000141588925012290/form4-05072025_080509.xml","form_type":"4"}},{"id":1155868,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47899,"kind":"person","name":"Ho William Tai-Wei","position":1,"cik":"0001830914","reported_name":"Ho William Tai-Wei","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Series A Warrants (right to buy)","published_at":"2025-05-08T00:45:13.000Z","date":"2025-05-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":81967,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Pursuant to an Exchange Letter Agreement, dated April 26, 2025 (the \"Exchange Agreement\"), by and between the Company and the Reporting Person, the Reporting Person surrendered to the Company for cancellation the Series A Warrants for a like number of Pre-Funded Warrants to purchase common stock,  with a per share exercise price of $0.0001 per share."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported securities are included within 81,967 units purchased by the Reporting Person on December 13, 2023 for $1.22 per unit. Each unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 81,967 shares of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":0.45,"expiration_date":"2025-10-04","underlying":"Common Stock","underlying_shares":81967},"source":{"system":"sec-edgar","filing":"0001415889-25-012290","document":"form4-05072025_080509.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1740279/000141588925012290/form4-05072025_080509.xml","form_type":"4"}},{"id":1155867,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47899,"kind":"person","name":"Ho William Tai-Wei","position":1,"cik":"0001830914","reported_name":"Ho William Tai-Wei","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Series B Warrants (right to buy)","published_at":"2025-05-08T00:45:13.000Z","date":"2025-04-27","kind":"grant","planned":false,"acquired":true,"shares":81967,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the \"old\" warrant and the grant of a \"replacement\" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.50 per share. The exercise price was reduced to $0.45 per share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the \"old\" warrant and the grant of a \"replacement\" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.50 per share. The exercise price was reduced to $0.45 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested and exercisable."}],"balance_after":81967,"derivative":{"exercise_price":0.45,"expiration_date":"2028-12-13","underlying":"Common Stock","underlying_shares":81967},"source":{"system":"sec-edgar","filing":"0001415889-25-012290","document":"form4-05072025_080509.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1740279/000141588925012290/form4-05072025_080509.xml","form_type":"4"}},{"id":1155866,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47899,"kind":"person","name":"Ho William Tai-Wei","position":1,"cik":"0001830914","reported_name":"Ho William Tai-Wei","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Series B Warrants (right to buy)","published_at":"2025-05-08T00:45:13.000Z","date":"2025-04-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":81967,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the \"old\" warrant and the grant of a \"replacement\" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.50 per share. The exercise price was reduced to $0.45 per share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the \"old\" warrant and the grant of a \"replacement\" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.50 per share. The exercise price was reduced to $0.45 per share."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported securities are included within 81,967 units purchased by the Reporting Person on December 13, 2023 for $1.22 per Unit. Each Unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to\npurchase 81,967 shares of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":1.5,"expiration_date":"2028-12-13","underlying":"Common Stock","underlying_shares":81967},"source":{"system":"sec-edgar","filing":"0001415889-25-012290","document":"form4-05072025_080509.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1740279/000141588925012290/form4-05072025_080509.xml","form_type":"4"}},{"id":1278302,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47899,"kind":"person","name":"Ho William Tai-Wei","position":1,"cik":"0001830914","reported_name":"Ho William Tai-Wei","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-02-07T21:15:07.000Z","date":"2025-02-05","kind":"grant","planned":false,"acquired":true,"shares":912450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to the option shall vest on February 5, 2026 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":912450,"derivative":{"exercise_price":0.29,"expiration_date":"2035-02-05","underlying":"Common Stock","underlying_shares":912450},"source":{"system":"sec-edgar","filing":"0001415889-25-003343","document":"form4-02072025_040203.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1740279/000141588925003343/form4-02072025_040203.xml","form_type":"4"}},{"id":1322537,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47899,"kind":"person","name":"Ho William Tai-Wei","position":1,"cik":"0001830914","reported_name":"Ho William Tai-Wei","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-12-23T21:15:07.000Z","date":"2024-12-19","kind":"grant","planned":false,"acquired":true,"shares":1188282,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest on December 19, 2025, subject to the Reporting Person continuing to provide service on such date."}],"balance_after":1188282,"derivative":{"exercise_price":0.24,"expiration_date":"2034-12-19","underlying":"Common Stock","underlying_shares":1188282},"source":{"system":"sec-edgar","filing":"0001415889-24-030056","document":"form4-12232024_041204.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1740279/000141588924030056/form4-12232024_041204.xml","form_type":"4"}},{"id":1389002,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47899,"kind":"person","name":"Ho William Tai-Wei","position":1,"cik":"0001830914","reported_name":"Ho William Tai-Wei","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Series C Warrants (right to buy)","published_at":"2024-10-08T20:15:06.000Z","date":"2024-10-04","kind":"grant","planned":false,"acquired":true,"shares":126582,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 126,582 Issuer Units purchased by the Reporting Person for $0.395 per Unit. Each Unit consists of one share of common stock and one Series C warrant representing the right to purchase 126,582 shares of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully vested and exercisable."}],"balance_after":126582,"derivative":{"exercise_price":0.27,"expiration_date":"2027-10-04","underlying":"Common Stock","underlying_shares":126582},"source":{"system":"sec-edgar","filing":"0001415889-24-024866","document":"form4-10082024_041001.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1740279/000141588924024866/form4-10082024_041001.xml","form_type":"4"}},{"id":1389001,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47899,"kind":"person","name":"Ho William Tai-Wei","position":1,"cik":"0001830914","reported_name":"Ho William Tai-Wei","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Series A Warrants (right to buy)","published_at":"2024-10-08T20:15:06.000Z","date":"2024-10-04","kind":"grant","planned":false,"acquired":true,"shares":81967,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the \"old\" warrant and the grant of a \"replacement\" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.25 and expiration date of June 13, 2025. The exercise price was reduced to $0.45 and the warrant expiration date was extended to October 4, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the \"old\" warrant and the grant of a \"replacement\" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.25 and expiration date of June 13, 2025. The exercise price was reduced to $0.45 and the warrant expiration date was extended to October 4, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported securities are included within 81,967 Issuer Units purchased by the Reporting Person for $1.22 per Unit. Each Unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 81,967 shares of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully vested and exercisable."}],"balance_after":81967,"derivative":{"exercise_price":0.45,"expiration_date":"2025-10-04","underlying":"Common Stock","underlying_shares":81967},"source":{"system":"sec-edgar","filing":"0001415889-24-024866","document":"form4-10082024_041001.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1740279/000141588924024866/form4-10082024_041001.xml","form_type":"4"}},{"id":1389000,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47899,"kind":"person","name":"Ho William Tai-Wei","position":1,"cik":"0001830914","reported_name":"Ho William Tai-Wei","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Series A Warrants (right to buy)","published_at":"2024-10-08T20:15:06.000Z","date":"2024-10-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":81967,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the \"old\" warrant and the grant of a \"replacement\" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.25 and expiration date of June 13, 2025. The exercise price was reduced to $0.45 and the warrant expiration date was extended to October 4, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the \"old\" warrant and the grant of a \"replacement\" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.25 and expiration date of June 13, 2025. The exercise price was reduced to $0.45 and the warrant expiration date was extended to October 4, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported securities are included within 81,967 Issuer Units purchased by the Reporting Person for $1.22 per Unit. Each Unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 81,967 shares of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":1.25,"expiration_date":"2025-06-13","underlying":"Common Stock","underlying_shares":81967},"source":{"system":"sec-edgar","filing":"0001415889-24-024866","document":"form4-10082024_041001.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1740279/000141588924024866/form4-10082024_041001.xml","form_type":"4"}},{"id":1388999,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47899,"kind":"person","name":"Ho William Tai-Wei","position":1,"cik":"0001830914","reported_name":"Ho William Tai-Wei","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-10-08T20:15:06.000Z","date":"2024-10-04","kind":"grant","planned":false,"acquired":true,"shares":126582,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 126,582 Issuer Units purchased by the Reporting Person for $0.395 per Unit. Each Unit consists of one share of common stock and one Series C warrant representing the right to purchase 126,582 shares of common stock."}],"balance_after":2548094,"source":{"system":"sec-edgar","filing":"0001415889-24-024866","document":"form4-10082024_041001.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1740279/000141588924024866/form4-10082024_041001.xml","form_type":"4"}},{"id":1413459,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47899,"kind":"person","name":"Ho William Tai-Wei","position":1,"cik":"0001830914","reported_name":"Ho William Tai-Wei","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-09-05T20:35:06.000Z","date":"2024-09-04","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents a retention award in the form of an option to purchase common stock. Twenty-five percent (25%) of the shares subject to the option shall vest on each of March 4, 2025 and September 4, 2025 and fifty percent (50%) of the shares subject to the option shall vest on March 4, 2026, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":500000,"derivative":{"exercise_price":0.47,"expiration_date":"2034-09-04","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001415889-24-022925","document":"form4-09052024_040903.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1740279/000141588924022925/form4-09052024_040903.xml","form_type":"4"}},{"id":1652960,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47899,"kind":"person","name":"Ho William Tai-Wei","position":1,"cik":"0001830914","reported_name":"Ho William Tai-Wei","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-02-08T21:52:21.000Z","date":"2024-02-07","kind":"grant","planned":false,"acquired":true,"shares":502000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to the option shall vest on February 7, 2025 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":502000,"derivative":{"exercise_price":1.22,"expiration_date":"2034-02-07","underlying":"Common Stock","underlying_shares":502000},"source":{"system":"sec-edgar","filing":"0001415889-24-003023","document":"form4-02082024_090210.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1740279/000141588924003023/form4-02082024_090210.xml","form_type":"4"}},{"id":1708665,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47899,"kind":"person","name":"Ho William Tai-Wei","position":1,"cik":"0001830914","reported_name":"Ho William Tai-Wei","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Series B Warrants (right to buy)","published_at":"2023-12-15T13:24:30.000Z","date":"2023-12-13","kind":"grant","planned":false,"acquired":true,"shares":81967,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 81,967 Issuer Units purchased by the Reporting Person for $1.22 per Unit. Each Unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 81,967 shares of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully vested and exercisable."}],"balance_after":81967,"derivative":{"exercise_price":1.5,"expiration_date":"2028-12-13","underlying":"Common Stock","underlying_shares":81967},"source":{"system":"sec-edgar","filing":"0001209191-23-058718","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1740279/000120919123058718/doc4.xml","form_type":"4"}},{"id":1708664,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47899,"kind":"person","name":"Ho William Tai-Wei","position":1,"cik":"0001830914","reported_name":"Ho William Tai-Wei","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Series A  Warrants (right to buy)","published_at":"2023-12-15T13:24:30.000Z","date":"2023-12-13","kind":"grant","planned":false,"acquired":true,"shares":81967,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 81,967 Issuer Units purchased by the Reporting Person for $1.22 per Unit. Each Unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 81,967 shares of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully vested and exercisable."}],"balance_after":81967,"derivative":{"exercise_price":1.25,"expiration_date":"2025-06-13","underlying":"Common Stock","underlying_shares":81967},"source":{"system":"sec-edgar","filing":"0001209191-23-058718","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1740279/000120919123058718/doc4.xml","form_type":"4"}},{"id":1708663,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47899,"kind":"person","name":"Ho William Tai-Wei","position":1,"cik":"0001830914","reported_name":"Ho William Tai-Wei","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-12-15T13:24:30.000Z","date":"2023-12-13","kind":"grant","planned":false,"acquired":true,"shares":81967,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 81,967 Issuer Units purchased by the Reporting Person for $1.22 per Unit. Each Unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 81,967 shares of common stock."}],"balance_after":2421512,"source":{"system":"sec-edgar","filing":"0001209191-23-058718","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1740279/000120919123058718/doc4.xml","form_type":"4"}},{"id":1794995,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47899,"kind":"person","name":"Ho William Tai-Wei","position":1,"cik":"0001830914","reported_name":"Ho William Tai-Wei","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-08-28T20:42:02.000Z","date":"2023-08-24","kind":"purchase","planned":false,"acquired":true,"shares":23800,"price":1.05,"value":24990.0,"ownership":{"direct":true},"balance_after":2339545,"source":{"system":"sec-edgar","filing":"0001209191-23-047525","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1740279/000120919123047525/doc4.xml","form_type":"4"}},{"id":1844829,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47899,"kind":"person","name":"Ho William Tai-Wei","position":1,"cik":"0001830914","reported_name":"Ho William Tai-Wei","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-06-23T22:25:58.000Z","date":"2023-06-21","kind":"grant","planned":false,"acquired":true,"shares":393950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to the option shall vest on June 21, 2024, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":393950,"derivative":{"exercise_price":2.01,"expiration_date":"2033-06-21","underlying":"Common Stock","underlying_shares":393950},"source":{"system":"sec-edgar","filing":"0001209191-23-039506","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1740279/000120919123039506/doc4.xml","form_type":"4"}},{"id":1844828,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47899,"kind":"person","name":"Ho William Tai-Wei","position":1,"cik":"0001830914","reported_name":"Ho William Tai-Wei","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-06-23T22:25:13.000Z","date":"2023-04-14","kind":"grant","planned":false,"acquired":true,"shares":393950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The initial Form 4 inadvertently listed the wrong exercise price and expiration date. This amendment reflects the revised exercise price and expiration date for this option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Twenty-five percent (25%) of the shares subject to the option shall vest on April 14, 2024 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The initial Form 4 inadvertently listed the wrong exercise price and expiration date. This amendment reflects the revised exercise price and expiration date for this option."}],"balance_after":393950,"derivative":{"exercise_price":1.21,"expiration_date":"2033-04-14","underlying":"Common Stock","underlying_shares":393950},"source":{"system":"sec-edgar","filing":"0001209191-23-039505","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1740279/000120919123039505/doc4a.xml","form_type":"4/A","original_submission_date":"2023-04-18"}},{"id":1917792,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47899,"kind":"person","name":"Ho William Tai-Wei","position":1,"cik":"0001830914","reported_name":"Ho William Tai-Wei","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-04-18T21:01:41.000Z","date":"2023-04-14","kind":"grant","planned":false,"acquired":true,"shares":393950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to the option shall vest on April 14, 2024 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":393950,"derivative":{"exercise_price":1.34,"expiration_date":"2028-04-14","underlying":"Common Stock","underlying_shares":393950},"source":{"system":"sec-edgar","filing":"0001209191-23-024694","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1740279/000120919123024694/doc4.xml","form_type":"4"}},{"id":2132146,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47899,"kind":"person","name":"Ho William Tai-Wei","position":1,"cik":"0001830914","reported_name":"Ho William Tai-Wei","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and CFO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-10-25T20:33:55.000Z","date":"2022-10-21","kind":"grant","acquired":true,"shares":83265,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in three equal annual installments commencing on October 21, 2024, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":83265,"derivative":{"exercise_price":1.48,"expiration_date":"2032-10-21","underlying":"Common Stock","underlying_shares":83265},"source":{"system":"sec-edgar","filing":"0001209191-22-054507","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1740279/000120919122054507/doc4.xml","form_type":"4"}},{"id":2179083,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47899,"kind":"person","name":"Ho William Tai-Wei","position":1,"cik":"0001830914","reported_name":"Ho William Tai-Wei","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and CFO"}}],"security":"Common Stock","published_at":"2022-08-18T20:15:49.000Z","date":"2022-08-16","kind":"purchase","acquired":true,"shares":26315,"price":1.9,"value":49998.5,"ownership":{"direct":true},"balance_after":2315745,"source":{"system":"sec-edgar","filing":"0001209191-22-046615","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1740279/000120919122046615/doc4.xml","form_type":"4"}},{"id":2387310,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47899,"kind":"person","name":"Ho William Tai-Wei","position":1,"cik":"0001830914","reported_name":"Ho William Tai-Wei","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and CFO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-02-17T21:34:54.000Z","date":"2022-02-15","kind":"grant","acquired":true,"shares":254500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to the option shall vest on February 15, 2023 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":254500,"derivative":{"exercise_price":4.28,"expiration_date":"2032-02-15","underlying":"Common Stock","underlying_shares":254500},"source":{"system":"sec-edgar","filing":"0001209191-22-010785","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1740279/000120919122010785/doc4.xml","form_type":"4"}},{"id":2616651,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47899,"kind":"person","name":"Ho William Tai-Wei","position":1,"cik":"0001830914","reported_name":"Ho William Tai-Wei","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and CFO"}}],"security":"Series A Preferred Stock","published_at":"2021-08-03T20:55:06.000Z","date":"2021-08-03","kind":"exercise","acquired":false,"shares":2792,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By child"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock was convertible at any time at the option of the holder, without payment of additional consideration, into\nCommon Stock, on a 1.0997 for 1 basis, had no expiration date and automatically converted into shares of Common Stock upon the\nclosing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock was convertible at any time at the option of the holder, without payment of additional consideration, into\nCommon Stock, on a 1.0997 for 1 basis, had no expiration date and automatically converted into shares of Common Stock upon the\nclosing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock was convertible at any time at the option of the holder, without payment of additional consideration, into\nCommon Stock, on a 1.0997 for 1 basis, had no expiration date and automatically converted into shares of Common Stock upon the\nclosing of the Issuer's initial public offering."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3070},"source":{"system":"sec-edgar","filing":"0001209191-21-049376","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1740279/000120919121049376/doc4.xml","form_type":"4"}},{"id":2616650,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47899,"kind":"person","name":"Ho William Tai-Wei","position":1,"cik":"0001830914","reported_name":"Ho William Tai-Wei","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and CFO"}}],"security":"Common Stock","published_at":"2021-08-03T20:55:06.000Z","date":"2021-08-03","kind":"exercise","acquired":true,"shares":3070,"ownership":{"direct":false,"nature":"By child"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock was convertible at any time at the option of the holder, without payment of additional consideration, into\nCommon Stock, on a 1.0997 for 1 basis, had no expiration date and automatically converted into shares of Common Stock upon the\nclosing of the Issuer's initial public offering."}],"balance_after":72999,"source":{"system":"sec-edgar","filing":"0001209191-21-049376","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1740279/000120919121049376/doc4.xml","form_type":"4"}},{"id":2619638,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47899,"kind":"person","name":"Ho William Tai-Wei","position":1,"cik":"0001830914","reported_name":"Ho William Tai-Wei","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and CFO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-08-03T01:30:28.000Z","date":"2021-07-29","kind":"grant","acquired":true,"shares":220500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One forty-eighth (1/48th) of the shares subject to the option shall vest in   equal monthly installments commencing on August 29, 2021, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":220500,"derivative":{"exercise_price":10,"expiration_date":"2031-07-29","underlying":"Common Stock","underlying_shares":220500},"source":{"system":"sec-edgar","filing":"0001209191-21-049157","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1740279/000120919121049157/doc4.xml","form_type":"4"}}]}